| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TNFRSF25 ERBB4 ABCA1 ZNF219 HMCN2 EDAR FZD5 LRP5 GPRC5D LTBP1 NOTCH1 NOTCH2 | 6.32e-05 | 1353 | 48 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.65e-05 | 188 | 48 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 7.52e-04 | 17 | 48 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | ligase activity | 8.04e-04 | 174 | 48 | 4 | GO:0016874 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.05e-03 | 20 | 48 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.05e-03 | 20 | 48 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 1.64e-03 | 25 | 48 | 2 | GO:0005243 | |
| GeneOntologyMolecularFunction | Notch binding | 1.91e-03 | 27 | 48 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.06e-03 | 28 | 48 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | protein kinase activity | 3.01e-03 | 600 | 48 | 6 | GO:0004672 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 3.02e-03 | 34 | 48 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 3.57e-03 | 37 | 48 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 4.58e-03 | 42 | 48 | 2 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 4.58e-03 | 42 | 48 | 2 | GO:0004812 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 5.97e-06 | 50 | 49 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 6.86e-06 | 571 | 49 | 9 | GO:0043410 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.51e-05 | 63 | 49 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.66e-05 | 3 | 49 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | heart valve development | 3.52e-05 | 78 | 49 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | MAPK cascade | ERBB4 EDAR FZD5 ADAM9 BMPER MAP3K21 MAP2K7 NOTCH1 NOTCH2 TP73 | 5.48e-05 | 930 | 49 | 10 | GO:0000165 |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 5.95e-05 | 32 | 49 | 3 | GO:0060561 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 7.82e-05 | 35 | 49 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.08e-04 | 39 | 49 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 1.11e-04 | 815 | 49 | 9 | GO:0043408 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 1.36e-04 | 42 | 49 | 3 | GO:0003230 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.44e-04 | 212 | 49 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.53e-04 | 850 | 49 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.78e-04 | 46 | 49 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 1.90e-04 | 47 | 49 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 1.97e-04 | 9 | 49 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 1.97e-04 | 9 | 49 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 1.97e-04 | 9 | 49 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.04e-04 | 883 | 49 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 2.14e-04 | 364 | 49 | 6 | GO:0071216 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 2.57e-04 | 240 | 49 | 5 | GO:0070374 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.88e-04 | 134 | 49 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | heart development | 3.77e-04 | 757 | 49 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | circulatory system development | ERBB4 CAD DLL4 FZD5 SLIT3 LRP5 LTBP1 BMPER NOTCH1 NOTCH2 TP73 | 4.61e-04 | 1442 | 49 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | response to laminar fluid shear stress | 4.94e-04 | 14 | 49 | 2 | GO:0034616 | |
| GeneOntologyBiologicalProcess | negative regulation of hematopoietic progenitor cell differentiation | 4.94e-04 | 14 | 49 | 2 | GO:1901533 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 4.94e-04 | 14 | 49 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell proliferation | 4.96e-04 | 65 | 49 | 3 | GO:0060043 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.64e-04 | 285 | 49 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | regulation of developmental pigmentation | 5.69e-04 | 15 | 49 | 2 | GO:0048070 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.73e-04 | 286 | 49 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 5.76e-04 | 161 | 49 | 4 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 5.76e-04 | 161 | 49 | 4 | GO:0003231 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.22e-04 | 445 | 49 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 7.22e-04 | 171 | 49 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 7.25e-04 | 74 | 49 | 3 | GO:0002011 | |
| GeneOntologyBiologicalProcess | regulation of pigmentation | 7.35e-04 | 17 | 49 | 2 | GO:0120305 | |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 7.35e-04 | 17 | 49 | 2 | GO:0003222 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 8.39e-04 | 178 | 49 | 4 | GO:0022612 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 9.10e-04 | 80 | 49 | 3 | GO:2000179 | |
| GeneOntologyBiologicalProcess | aorta development | 9.10e-04 | 80 | 49 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.42e-04 | 482 | 49 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 9.69e-04 | 185 | 49 | 4 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 9.69e-04 | 185 | 49 | 4 | GO:0035108 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 9.78e-04 | 82 | 49 | 3 | GO:0060038 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.02e-03 | 20 | 49 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.05e-03 | 327 | 49 | 5 | GO:0048738 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.24e-03 | 89 | 49 | 3 | GO:0060411 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.32e-03 | 91 | 49 | 3 | GO:0003281 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.36e-03 | 347 | 49 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.39e-03 | 204 | 49 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.40e-03 | 349 | 49 | 5 | GO:0014706 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.15e-04 | 658 | 48 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.98e-04 | 656 | 48 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | connexin complex | 1.16e-03 | 22 | 48 | 2 | GO:0005922 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.28e-03 | 530 | 48 | 6 | GO:0062023 | |
| MousePheno | abnormal induced retina neovascularization | 2.79e-05 | 21 | 40 | 3 | MP:0009660 | |
| MousePheno | abnormal myocardial trabeculae morphology | 5.33e-05 | 144 | 40 | 5 | MP:0002189 | |
| Domain | EGF-like_dom | 6.21e-10 | 249 | 48 | 10 | IPR000742 | |
| Domain | EGF | 7.42e-09 | 235 | 48 | 9 | SM00181 | |
| Domain | EGF_1 | 1.51e-08 | 255 | 48 | 9 | PS00022 | |
| Domain | EGF-like_CS | 1.85e-08 | 261 | 48 | 9 | IPR013032 | |
| Domain | EGF_2 | 2.10e-08 | 265 | 48 | 9 | PS01186 | |
| Domain | EGF-like_Ca-bd_dom | 2.82e-08 | 124 | 48 | 7 | IPR001881 | |
| Domain | EGF_3 | 1.36e-07 | 235 | 48 | 8 | PS50026 | |
| Domain | Growth_fac_rcpt_ | 1.37e-07 | 156 | 48 | 7 | IPR009030 | |
| Domain | EGF_CA | 1.95e-07 | 99 | 48 | 6 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.93e-07 | 106 | 48 | 6 | IPR000152 | |
| Domain | EGF_CA | 6.73e-07 | 122 | 48 | 6 | SM00179 | |
| Domain | EGF | 8.14e-07 | 126 | 48 | 6 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 4.89e-06 | 97 | 48 | 5 | IPR018097 | |
| Domain | ASX_HYDROXYL | 5.67e-06 | 100 | 48 | 5 | PS00010 | |
| Domain | DUF3454 | 1.94e-05 | 3 | 48 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.94e-05 | 3 | 48 | 2 | IPR024600 | |
| Domain | DUF3454 | 1.94e-05 | 3 | 48 | 2 | SM01334 | |
| Domain | Notch | 3.87e-05 | 4 | 48 | 2 | IPR008297 | |
| Domain | NODP | 3.87e-05 | 4 | 48 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 3.87e-05 | 4 | 48 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 3.87e-05 | 4 | 48 | 2 | IPR010660 | |
| Domain | NOD | 3.87e-05 | 4 | 48 | 2 | PF06816 | |
| Domain | NOD | 3.87e-05 | 4 | 48 | 2 | SM01338 | |
| Domain | NODP | 3.87e-05 | 4 | 48 | 2 | SM01339 | |
| Domain | LNR | 6.44e-05 | 5 | 48 | 2 | PS50258 | |
| Domain | EGF_CA | 6.99e-05 | 86 | 48 | 4 | PF07645 | |
| Domain | Notch_dom | 1.35e-04 | 7 | 48 | 2 | IPR000800 | |
| Domain | Notch | 1.35e-04 | 7 | 48 | 2 | PF00066 | |
| Domain | NL | 1.35e-04 | 7 | 48 | 2 | SM00004 | |
| Domain | TIL | 4.20e-04 | 12 | 48 | 2 | PF01826 | |
| Domain | C8 | 4.20e-04 | 12 | 48 | 2 | PF08742 | |
| Domain | EGF_extracell | 4.92e-04 | 60 | 48 | 3 | IPR013111 | |
| Domain | EGF_2 | 4.92e-04 | 60 | 48 | 3 | PF07974 | |
| Domain | Unchr_dom_Cys-rich | 4.95e-04 | 13 | 48 | 2 | IPR014853 | |
| Domain | C8 | 4.95e-04 | 13 | 48 | 2 | SM00832 | |
| Domain | TIL_dom | 5.77e-04 | 14 | 48 | 2 | IPR002919 | |
| Domain | VWD | 7.58e-04 | 16 | 48 | 2 | SM00216 | |
| Domain | VWF_type-D | 7.58e-04 | 16 | 48 | 2 | IPR001846 | |
| Domain | VWFD | 7.58e-04 | 16 | 48 | 2 | PS51233 | |
| Domain | VWD | 7.58e-04 | 16 | 48 | 2 | PF00094 | |
| Domain | CONNEXINS_1 | 1.08e-03 | 19 | 48 | 2 | PS00407 | |
| Domain | CONNEXINS_2 | 1.19e-03 | 20 | 48 | 2 | PS00408 | |
| Domain | Connexin | 1.19e-03 | 20 | 48 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 1.19e-03 | 20 | 48 | 2 | IPR019570 | |
| Domain | Connexin_N | 1.19e-03 | 20 | 48 | 2 | IPR013092 | |
| Domain | Connexin | 1.19e-03 | 20 | 48 | 2 | PF00029 | |
| Domain | Connexin_CCC | 1.19e-03 | 20 | 48 | 2 | SM01089 | |
| Domain | Connexin_CS | 1.19e-03 | 20 | 48 | 2 | IPR017990 | |
| Domain | CNX | 1.19e-03 | 20 | 48 | 2 | SM00037 | |
| Domain | hEGF | 2.34e-03 | 28 | 48 | 2 | PF12661 | |
| Domain | TNFR_NGFR_1 | 2.51e-03 | 29 | 48 | 2 | PS00652 | |
| Domain | TNFR_NGFR_2 | 2.51e-03 | 29 | 48 | 2 | PS50050 | |
| Domain | Death | 3.25e-03 | 33 | 48 | 2 | PF00531 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 3.25e-03 | 33 | 48 | 2 | IPR001368 | |
| Domain | Death_domain | 4.29e-03 | 38 | 48 | 2 | IPR000488 | |
| Domain | VWC | 4.29e-03 | 38 | 48 | 2 | SM00214 | |
| Domain | DEATH_DOMAIN | 4.29e-03 | 38 | 48 | 2 | PS50017 | |
| Domain | LAM_G_DOMAIN | 4.29e-03 | 38 | 48 | 2 | PS50025 | |
| Domain | Peptidase_M12B_N | 4.51e-03 | 39 | 48 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 4.51e-03 | 39 | 48 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 4.74e-03 | 40 | 48 | 2 | PS00427 | |
| Domain | Reprolysin | 4.74e-03 | 40 | 48 | 2 | PF01421 | |
| Domain | Laminin_G_2 | 4.74e-03 | 40 | 48 | 2 | PF02210 | |
| Domain | ADAM_MEPRO | 4.74e-03 | 40 | 48 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.74e-03 | 40 | 48 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 4.74e-03 | 40 | 48 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 4.98e-03 | 41 | 48 | 2 | IPR001762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.94e-06 | 13 | 40 | 3 | M47423 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.96e-05 | 118 | 40 | 5 | M39852 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.91e-05 | 27 | 40 | 3 | M39545 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 7.05e-05 | 154 | 40 | 5 | M39739 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 7.81e-05 | 5 | 40 | 2 | M27411 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.70e-05 | 161 | 40 | 5 | M39770 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.04e-04 | 87 | 40 | 4 | M39465 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.17e-04 | 6 | 40 | 2 | M27068 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.59e-04 | 97 | 40 | 4 | MM15926 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.63e-04 | 7 | 40 | 2 | M27199 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.86e-04 | 101 | 40 | 4 | M39448 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 2.17e-04 | 8 | 40 | 2 | M27433 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.77e-04 | 45 | 40 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.95e-04 | 46 | 40 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.15e-04 | 47 | 40 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 4.25e-04 | 11 | 40 | 2 | M47865 | |
| Pathway | BIOCARTA_HES_PATHWAY | 5.09e-04 | 12 | 40 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 5.09e-04 | 12 | 40 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 5.09e-04 | 12 | 40 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 5.09e-04 | 12 | 40 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 5.09e-04 | 12 | 40 | 2 | M47929 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 6.00e-04 | 13 | 40 | 2 | M47534 | |
| Pathway | PID_NOTCH_PATHWAY | 6.16e-04 | 59 | 40 | 3 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 6.80e-04 | 61 | 40 | 3 | M39540 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.99e-04 | 143 | 40 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 6.99e-04 | 14 | 40 | 2 | M47834 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 8.05e-04 | 15 | 40 | 2 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 9.19e-04 | 16 | 40 | 2 | M47424 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.33e-04 | 68 | 40 | 3 | M27303 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.04e-03 | 17 | 40 | 2 | M39389 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.17e-03 | 18 | 40 | 2 | M614 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.44e-03 | 20 | 40 | 2 | M27881 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.44e-03 | 20 | 40 | 2 | MM15155 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.59e-03 | 21 | 40 | 2 | M27401 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.60e-03 | 82 | 40 | 3 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.60e-03 | 82 | 40 | 3 | MM15922 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.75e-03 | 22 | 40 | 2 | M27210 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.08e-03 | 24 | 40 | 2 | M11190 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 2.44e-03 | 26 | 40 | 2 | MM15270 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 2.83e-03 | 28 | 40 | 2 | M77 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.83e-03 | 28 | 40 | 2 | M6177 | |
| Pathway | WP_CANCER_PATHWAYS | 2.85e-03 | 507 | 40 | 6 | M48302 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 3.04e-03 | 29 | 40 | 2 | M29808 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 3.04e-03 | 29 | 40 | 2 | M27555 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 3.47e-03 | 31 | 40 | 2 | M592 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.47e-03 | 31 | 40 | 2 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.47e-03 | 31 | 40 | 2 | MM15154 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.69e-03 | 32 | 40 | 2 | MM14730 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 3.69e-03 | 32 | 40 | 2 | M40041 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.92e-03 | 33 | 40 | 2 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 4.16e-03 | 34 | 40 | 2 | M27405 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 4.16e-03 | 34 | 40 | 2 | M39390 | |
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 2.63e-09 | 3 | 49 | 3 | 27073072 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 33351914 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.05e-08 | 4 | 49 | 3 | 32820046 | |
| Pubmed | 1.33e-08 | 19 | 49 | 4 | 25691540 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 23675950 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 30181175 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 35064244 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 32060138 | ||
| Pubmed | Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. | 9.16e-08 | 7 | 49 | 3 | 27576369 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 30289388 | ||
| Pubmed | 2.19e-07 | 9 | 49 | 3 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 3.13e-07 | 10 | 49 | 3 | 23665443 | |
| Pubmed | 3.13e-07 | 10 | 49 | 3 | 24015274 | ||
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 7.44e-07 | 13 | 49 | 3 | 11578869 | |
| Pubmed | 7.63e-07 | 50 | 49 | 4 | 27510977 | ||
| Pubmed | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. | 9.46e-07 | 14 | 49 | 3 | 21402699 | |
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 14757642 | ||
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.45e-06 | 16 | 49 | 3 | 12617809 | |
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 17273555 | ||
| Pubmed | Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. | 1.49e-06 | 59 | 49 | 4 | 26450967 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.76e-06 | 17 | 49 | 3 | 15821257 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 39315665 | ||
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 1.94e-06 | 2 | 49 | 2 | 17652726 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 1.94e-06 | 2 | 49 | 2 | 24508387 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11739188 | ||
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 1.94e-06 | 2 | 49 | 2 | 25041344 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 1.94e-06 | 2 | 49 | 2 | 23380742 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35617425 | ||
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 1.94e-06 | 2 | 49 | 2 | 25866967 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32423029 | ||
| Pubmed | NOTCH1 and DLL4 are involved in the human tuberculosis progression and immune response activation. | 1.94e-06 | 2 | 49 | 2 | 32801053 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21466361 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20069650 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15625786 | ||
| Pubmed | Notch2 signaling is required for potent antitumor immunity in vivo. | 1.94e-06 | 2 | 49 | 2 | 20351182 | |
| Pubmed | Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. | 1.94e-06 | 2 | 49 | 2 | 23787764 | |
| Pubmed | Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymus. | 1.94e-06 | 2 | 49 | 2 | 21598246 | |
| Pubmed | A novel IgA/Delta-like 4/Notch axis induces immunosuppressive activity in human dendritic cells. | 1.94e-06 | 2 | 49 | 2 | 27117596 | |
| Pubmed | The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. | 1.94e-06 | 2 | 49 | 2 | 21700774 | |
| Pubmed | Involvement of Notch in activation and effector functions of γδ T cells. | 1.94e-06 | 2 | 49 | 2 | 24489102 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31676012 | ||
| Pubmed | Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. | 1.94e-06 | 2 | 49 | 2 | 17261636 | |
| Pubmed | Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. | 1.94e-06 | 2 | 49 | 2 | 8440332 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 33469672 | ||
| Pubmed | The Notch pathway in podocytes plays a role in the development of glomerular disease. | 1.94e-06 | 2 | 49 | 2 | 18311147 | |
| Pubmed | Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. | 1.94e-06 | 2 | 49 | 2 | 25141821 | |
| Pubmed | Differential expression of Notch1 and Notch2 in developing and adult mouse brain. | 1.94e-06 | 2 | 49 | 2 | 7609614 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 33017398 | ||
| Pubmed | DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. | 1.94e-06 | 2 | 49 | 2 | 25355291 | |
| Pubmed | Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. | 1.94e-06 | 2 | 49 | 2 | 21285514 | |
| Pubmed | Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. | 1.94e-06 | 2 | 49 | 2 | 18353145 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22205705 | ||
| Pubmed | Notch signaling induces cell cycle arrest in small cell lung cancer cells. | 1.94e-06 | 2 | 49 | 2 | 11306509 | |
| Pubmed | Correlation of asymmetric Notch2 expression and mouse incisor rotation. | 1.94e-06 | 2 | 49 | 2 | 10704869 | |
| Pubmed | Notch signaling is necessary but not sufficient for differentiation of dendritic cells. | 1.94e-06 | 2 | 49 | 2 | 12907456 | |
| Pubmed | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. | 1.94e-06 | 2 | 49 | 2 | 26933171 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21693515 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23589286 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20193271 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8917536 | ||
| Pubmed | Functional conservation of Notch1 and Notch2 intracellular domains. | 1.94e-06 | 2 | 49 | 2 | 15897231 | |
| Pubmed | Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis. | 1.94e-06 | 2 | 49 | 2 | 27564686 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35725756 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30296524 | ||
| Pubmed | Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. | 1.94e-06 | 2 | 49 | 2 | 12753746 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25982147 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25766473 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19701457 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26041884 | ||
| Pubmed | Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. | 1.94e-06 | 2 | 49 | 2 | 28820917 | |
| Pubmed | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. | 1.94e-06 | 2 | 49 | 2 | 22006338 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19339697 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15492845 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29643502 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19915064 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26070613 | ||
| Pubmed | Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. | 1.94e-06 | 2 | 49 | 2 | 27776108 | |
| Pubmed | Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro. | 1.94e-06 | 2 | 49 | 2 | 31316119 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18666240 | ||
| Pubmed | In vivo mapping of notch pathway activity in normal and stress hematopoiesis. | 1.94e-06 | 2 | 49 | 2 | 23791481 | |
| Pubmed | Dll4, a novel Notch ligand expressed in arterial endothelium. | 1.94e-06 | 2 | 49 | 2 | 10837024 | |
| Pubmed | 2.11e-06 | 18 | 49 | 3 | 18093989 | ||
| Pubmed | 2.11e-06 | 18 | 49 | 3 | 15689374 | ||
| Pubmed | 2.51e-06 | 19 | 49 | 3 | 20335360 | ||
| Pubmed | 2.51e-06 | 19 | 49 | 3 | 16518823 | ||
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 2.95e-06 | 20 | 49 | 3 | 23314057 | |
| Pubmed | 3.43e-06 | 21 | 49 | 3 | 28656980 | ||
| Pubmed | 3.97e-06 | 22 | 49 | 3 | 21750033 | ||
| Pubmed | 4.56e-06 | 23 | 49 | 3 | 14701881 | ||
| Pubmed | Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. | 4.56e-06 | 23 | 49 | 3 | 19897741 | |
| Pubmed | 4.56e-06 | 23 | 49 | 3 | 38582368 | ||
| Pubmed | 4.56e-06 | 23 | 49 | 3 | 24337118 | ||
| Pubmed | 4.56e-06 | 23 | 49 | 3 | 36239412 | ||
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 21633169 | ||
| Pubmed | Reduced Notch signaling leads to renal cysts and papillary microadenomas. | 5.83e-06 | 3 | 49 | 2 | 20378824 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22396647 | ||
| Pubmed | Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas. | 5.83e-06 | 3 | 49 | 2 | 28796347 | |
| Interaction | IGSF5 interactions | 4.25e-06 | 14 | 47 | 3 | int:IGSF5 | |
| Interaction | NTN5 interactions | 2.32e-05 | 24 | 47 | 3 | int:NTN5 | |
| Interaction | IGFL3 interactions | 2.80e-05 | 75 | 47 | 4 | int:IGFL3 | |
| Interaction | NOTCH2 interactions | 5.20e-05 | 423 | 47 | 7 | int:NOTCH2 | |
| Interaction | DLL4 interactions | 7.94e-05 | 6 | 47 | 2 | int:DLL4 | |
| Interaction | WNT10A interactions | 8.74e-05 | 37 | 47 | 3 | int:WNT10A | |
| Cytoband | 2p22-p21 | 3.11e-05 | 8 | 49 | 2 | 2p22-p21 | |
| GeneFamily | Gap junction proteins | 7.74e-04 | 22 | 34 | 2 | 314 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.35e-03 | 29 | 34 | 2 | 782 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.49e-06 | 191 | 49 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.73e-06 | 196 | 49 | 6 | M3008 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 2.44e-06 | 208 | 49 | 6 | M39139 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.38e-06 | 16 | 49 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.38e-06 | 16 | 49 | 3 | M2207 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP | 3.82e-06 | 126 | 49 | 5 | M8791 | |
| Coexpression | NABA_CORE_MATRISOME | 1.09e-05 | 270 | 49 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.21e-05 | 275 | 49 | 6 | M5884 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.93e-05 | 32 | 49 | 3 | M5903 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN | 3.32e-05 | 197 | 49 | 5 | M6525 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 9.52e-05 | 8 | 49 | 2 | M9884 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 5.79e-05 | 95 | 47 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.96e-05 | 195 | 47 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.83e-06 | 185 | 49 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.93e-06 | 187 | 49 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 188 | 49 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 190 | 49 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-06 | 192 | 49 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 193 | 49 | 5 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 49 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-06 | 195 | 49 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.37e-06 | 195 | 49 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-06 | 196 | 49 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.56e-06 | 198 | 49 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-05 | 159 | 49 | 4 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 161 | 49 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 162 | 49 | 4 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 162 | 49 | 4 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.17e-05 | 164 | 49 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.82e-05 | 172 | 49 | 4 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 174 | 49 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 174 | 49 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-05 | 176 | 49 | 4 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 181 | 49 | 4 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 181 | 49 | 4 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 181 | 49 | 4 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.97e-05 | 184 | 49 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 184 | 49 | 4 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.97e-05 | 184 | 49 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.07e-05 | 185 | 49 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.18e-05 | 186 | 49 | 4 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 189 | 49 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.63e-05 | 190 | 49 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-05 | 191 | 49 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 191 | 49 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-05 | 192 | 49 | 4 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.86e-05 | 192 | 49 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-05 | 192 | 49 | 4 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.10e-05 | 194 | 49 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.10e-05 | 194 | 49 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.10e-05 | 194 | 49 | 4 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 194 | 49 | 4 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.22e-05 | 195 | 49 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.22e-05 | 195 | 49 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 6.22e-05 | 195 | 49 | 4 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.22e-05 | 195 | 49 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.22e-05 | 195 | 49 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 195 | 49 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.22e-05 | 195 | 49 | 4 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 196 | 49 | 4 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 196 | 49 | 4 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 6.35e-05 | 196 | 49 | 4 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.35e-05 | 196 | 49 | 4 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 6.35e-05 | 196 | 49 | 4 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 6.35e-05 | 196 | 49 | 4 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 196 | 49 | 4 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 196 | 49 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 196 | 49 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.35e-05 | 196 | 49 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.47e-05 | 197 | 49 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 6.47e-05 | 197 | 49 | 4 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.47e-05 | 197 | 49 | 4 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.47e-05 | 197 | 49 | 4 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.47e-05 | 197 | 49 | 4 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.47e-05 | 197 | 49 | 4 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.47e-05 | 197 | 49 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.47e-05 | 197 | 49 | 4 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 6.60e-05 | 198 | 49 | 4 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 6.60e-05 | 198 | 49 | 4 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.60e-05 | 198 | 49 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | COPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class | 6.60e-05 | 198 | 49 | 4 | 7904af61473cb20064f7a3a1e1bfe8d5913cf317 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-05 | 198 | 49 | 4 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.73e-05 | 199 | 49 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.73e-05 | 199 | 49 | 4 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-05 | 199 | 49 | 4 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-05 | 199 | 49 | 4 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; HL60; HG-U133A | 3.74e-06 | 199 | 48 | 6 | 1424_UP | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 2.70e-06 | 2 | 49 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 2.70e-06 | 2 | 49 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.06e-05 | 32 | 49 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Adams Oliver syndrome | 4.04e-05 | 6 | 49 | 2 | C0265268 | |
| Disease | Adams-Oliver syndrome 1 | 4.04e-05 | 6 | 49 | 2 | C4551482 | |
| Disease | Congenital defect of skull and scalp | 4.04e-05 | 6 | 49 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 4.04e-05 | 6 | 49 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.39e-05 | 41 | 49 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.39e-05 | 41 | 49 | 3 | C0858252 | |
| Disease | arabinose measurement | 5.64e-05 | 7 | 49 | 2 | EFO_0021030 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | pantothenate measurement | 7.52e-05 | 8 | 49 | 2 | EFO_0021034 | |
| Disease | hemangiopericytoma (is_marker_for) | 9.65e-05 | 9 | 49 | 2 | DOID:264 (is_marker_for) | |
| Disease | urate measurement, spine bone mineral density | 1.25e-04 | 58 | 49 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Malignant neoplasm of skin | 1.31e-04 | 59 | 49 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.31e-04 | 59 | 49 | 3 | C0037286 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.76e-04 | 12 | 49 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 2.57e-04 | 538 | 49 | 6 | C0678222 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.80e-04 | 15 | 49 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.80e-04 | 15 | 49 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.80e-04 | 15 | 49 | 2 | C0154091 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.62e-04 | 17 | 49 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Carcinoma of bladder | 4.06e-04 | 18 | 49 | 2 | C0699885 | |
| Disease | Schizophrenia | 6.03e-04 | 883 | 49 | 7 | C0036341 | |
| Disease | Cerebral Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0334583 | |
| Disease | Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 7.91e-04 | 25 | 49 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0338070 | |
| Disease | brain cancer (implicated_via_orthology) | 8.56e-04 | 26 | 49 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 9.23e-04 | 27 | 49 | 2 | C0334579 | |
| Disease | Lung Neoplasms | 9.81e-04 | 265 | 49 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 9.95e-04 | 266 | 49 | 4 | C0242379 | |
| Disease | cancer (implicated_via_orthology) | 1.02e-03 | 268 | 49 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.14e-03 | 30 | 49 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 1.30e-03 | 32 | 49 | 2 | C0149782 | |
| Disease | cervical cancer | 1.46e-03 | 34 | 49 | 2 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 1.55e-03 | 35 | 49 | 2 | C0007873 | |
| Disease | Bladder Neoplasm | 1.64e-03 | 140 | 49 | 3 | C0005695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGNCTNIVYPPCDVQ | 271 | Q2TAA5 | |
| GACVTQCPQTFVYNP | 256 | Q15303 | |
| NSRCYQPEPFACGIE | 171 | Q9NWN3 | |
| QGIICNANNPCFRYP | 71 | O95477 | |
| NQGANYACECPPNFT | 381 | Q9NR61 | |
| LYNATCVICNSPTNP | 1271 | O94823 | |
| ECPVVPSSQVYQCIN | 1636 | P59510 | |
| CPVCNELFPSNVYQV | 696 | Q6IQ32 | |
| TCPAVCNFQTGEYVV | 66 | Q9H8H0 | |
| DTNPLNGQYICTCPQ | 391 | Q04721 | |
| TCPQGYTGPNCQNLV | 1046 | P46531 | |
| IQAICFYECSPNLGP | 91 | A6ND01 | |
| FNTRGSYQCVDTPCP | 4921 | Q8NDA2 | |
| YYNQTTGLCQECPPC | 36 | Q9UNE0 | |
| CCNPIQETYFQQLAP | 661 | Q9NQG7 | |
| EPFYTCACPTGVQLQ | 316 | O75197 | |
| APPQEAGVQCTCQHY | 241 | Q9BQE6 | |
| EQCVNSPGSYQCVPC | 1011 | Q14766 | |
| CPYIVQCFGTFITNT | 176 | O14733 | |
| SIAAAVEVCQCPPGY | 716 | P24043 | |
| GVSPGYQTFVSCQQQ | 256 | Q9UHC3 | |
| GCPNCIEYFTSQGLQ | 501 | O15350 | |
| RTGQVPNCAVPCYQP | 211 | Q13467 | |
| PTCPGCVFEGVQYQE | 161 | Q8N8U9 | |
| QECPLQGNACPVTAY | 271 | Q9NZD1 | |
| PPAQYFQGCLLDACQ | 4686 | Q9Y6R7 | |
| FVCNTKQPGCPNVCY | 51 | Q9NTQ9 | |
| YSQCTQPCPPDTQGN | 116 | Q8IZF7 | |
| DVPEYCNGSSQFCQP | 481 | Q13443 | |
| QFCQPDVFIQNGYPC | 491 | Q13443 | |
| FICNTLQPGCNSVCY | 51 | P08034 | |
| CRGTSQYPCVQVYVN | 76 | Q86W47 | |
| SFSPCVPQCQTQGSY | 226 | Q5T749 | |
| STCFIYQPVANCQAP | 256 | A8MX34 | |
| YQPVANCQAPCSTKN | 261 | A8MX34 | |
| QLNAPYSCQAEGPCL | 36 | A2RTX5 | |
| PSSFLQQTCGNVPYC | 866 | Q5TCX8 | |
| QTVSTFSLPCCVPYN | 216 | Q8NE09 | |
| PGPACAYVNLNICAN | 1076 | P41252 | |
| PGQNCSNYTVRFLCP | 126 | O75339 | |
| FQVRECFGNTPNCPS | 986 | Q70EK8 | |
| NNYVCICPPNYTGEL | 1016 | O75094 | |
| NQPVGCSPSYRQVNC | 176 | Q6SA08 | |
| FLQQVNVYGVCVPGC | 576 | Q9Y2P5 | |
| FVYCTGCGPQPVLHQ | 11 | P12018 | |
| VPAQCQGNCTFSYLE | 1731 | Q86WI1 | |
| QVSQCVSSSPFYCQP | 126 | Q93038 | |
| QFCQTVGYPCVVRPS | 1076 | P27708 | |
| PCQTQTYVKCPAPCQ | 61 | Q5T750 | |
| IKSPAPCQTQTCYVQ | 121 | Q5T750 | |
| PCQTQTCYVQGASPC | 126 | Q5T750 | |
| YQEQAGSLACVPCPV | 1481 | P01266 | |
| IQCPNQGCEAVYSSV | 406 | Q96ME7 | |
| PPEFRCQVCGQSFTQ | 271 | Q9P2Y4 | |
| YPCNGQVIPTFCDTS | 246 | Q92802 |